Vytalyou raises ~$830K angel round to grow longevity healthcare network
What's the deal? VytalyouDealroom has a profile for this one. Try Dealroom →, a Mumbai-based longevity and preventive healthcare platform, has raised US$1.09M in an angel round at a valuation of around US$4.48M. The funding came from Chetan Jain of Pharma DoseDealroom has a profile for this one. Try Dealroom → and Ratan Jain of Venus IndustriesDealroom has a profile for this one. Try Dealroom →.
What does it do? Founded by molecular oncologist Dr Chirantan Bose and radiologist Dr Preetesh Bhandari, and incorporated in September 2025, Vytalyou combines diagnostics with preventive healthcare. Its focus is identifying health risks early and extending an individual's "healthspan."
Its Predictive Longevity Evaluation combines blood investigations, ultrasound imaging, body-composition analysis, and cardiovascular evaluation. The company also offers interventions including hyperbaric oxygen therapy, cryotherapy, photobiomodulation, and regenerative therapies.
Where's the money going? Vytalyou plans to expand its Mumbai network and enter other major Indian cities in 2027. It currently runs a centre in Powai and is setting up two more, in Juhu and Worli, to create a three-location network.
The signal: Preventive and longevity-focused healthcare is drawing early-stage capital in India, where diagnostics-led wellness models are testing demand in metros first. A modest angel round backing a network buildout suggests investors see room for physical-centre expansion before wider rollout.
Read more: business-standard.com
Image credit: lydia_shiningbrightly
